New hope for hard-to-treat myeloma: experimental drug enters phase 2 trial

NCT ID NCT07266441

Recruiting now Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

First seen Dec 29, 2025 · Last updated Jun 18, 2026 · Updated 24 times

Summary

This study tests an experimental drug called JNJ-79635322 in people with multiple myeloma that has returned or stopped responding after at least 3 prior treatments. The goal is to see how well the drug shrinks or controls the cancer. About 157 participants will receive the drug and be monitored for response and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Asan Medical Center
RECRUITING

Seoul, 05505, South Korea
Banner MD Anderson Cancer Center
RECRUITING

Gilbert, Arizona, 85234, United States
Cancer Care Specialists of Central Illinois
RECRUITING

O'Fallon, Illinois, 62269, United States
Cancer Specialists of North Florida
RECRUITING

Jacksonville, Florida, 32256, United States
Cancer and Blood Specialty Clinic
RECRUITING

Los Alamitos, California, 90720, United States
Chonnam National University Hwasun Hospital
RECRUITING

Jeollanam-do, 58128, South Korea
City of Hope
RECRUITING

Duarte, California, 91010, United States
City of Hope Orange County Lennar Foundation Cancer Center
RECRUITING

Irvine, California, 92618, United States
Cleveland Clinic Foundtation
RECRUITING

Cleveland, Ohio, 44195, United States
Colorado Blood Cancer Institute
RECRUITING

Denver, Colorado, 80218, United States
Emory University
RECRUITING

Atlanta, Georgia, 30322, United States
Ha'Emek Medical Center
RECRUITING

Afula, 1834111, Israel
Hadassah Medical Center
RECRUITING

Jerusalem, 9112000, Israel
Hillel Yaffe Medical Center
RECRUITING

Hadera, 3820302, Israel
Liv Hospital Ankara
RECRUITING

Ankara, 06680, Turkey (Türkiye)
MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Massachusetts General Hospital
RECRUITING

Boston, Massachusetts, 02114, United States
Memorial Antalya Hospital
RECRUITING

Antalya, 07025, Turkey (Türkiye)
Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States
Mission Cancer Blood
RECRUITING

Waukee, Iowa, 50263, United States
National Hospital Organization Okayama Medical Center
RECRUITING

Okayama, 701-1192, Japan
National Hospital Organization Shibukawa Medical Center
RECRUITING

Gunma, 377-0280, Japan
NorthWest Medical Specialties, PLLC
RECRUITING

Tacoma, Washington, 98405, United States
Northside Hospital Cancer Institute
RECRUITING

Atlanta, Georgia, 30342, United States
O Neal Comprehensive Cancer Center at UAB
RECRUITING

Birmingham, Alabama, 35294, United States
Oncology Associates of Oregon PC Willamette Valley Cancer Institute
RECRUITING

Eugene, Oregon, 97401, United States
Oncology Consultants Texas
RECRUITING

Houston, Texas, 77030, United States
Rabin Medical Center
RECRUITING

Petah Tikva, 4941492, Israel
Rocky Mountain Cancer Centers
RECRUITING

Aurora, Colorado, 80012, United States
Rutgers Cancer Institute
RECRUITING

New Brunswick, New Jersey, 08901, United States
SCRI Oncology Partners
RECRUITING

Nashville, Tennessee, 37203, United States
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie
RECRUITING

Krakow, 30 688, Poland
Samson Assuta Ashdod University Hospital
RECRUITING

Ashdod, 7747629, Israel
Samsung Medical Center
RECRUITING

Seoul, 06351, South Korea
Seoul National University Hospital
RECRUITING

Seoul, 03080, South Korea
Severance Hospital Yonsei University Health System
RECRUITING

Seoul, 03722, South Korea
Swietokrzyskie Centrum Onkologii SPZOZ w Kielcach
RECRUITING

Kielce, 25 734, Poland
Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza
RECRUITING

Brzozów, 36 200, Poland
Tel Aviv Sourasky Medical Center
RECRUITING

Tel Aviv, 6423906, Israel
Tennessee Oncology, PLLC
RECRUITING

Nashville, Tennessee, 37203, United States
Texas Oncology
RECRUITING

Austin, Texas, 78705, United States
Texas Oncology - Northeast
RECRUITING

Tyler, Texas, 75702, United States
The Catholic University of Korea Seoul St Marys Hospital
RECRUITING

Seoul, 06591, South Korea
University of California San Francisco
RECRUITING

San Francisco, California, 94143, United States
University of Iowa
RECRUITING

Iowa City, Iowa, 52242, United States
University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu
RECRUITING

Wroclaw, 50 367, Poland
Uniwersytecki Szpital Kliniczny w Poznaniu
RECRUITING

Poznan, 60-569, Poland
Virginia Cancer Specialists
RECRUITING

Fairfax, Virginia, 22031, United States
Virginia Oncology Associates
RECRUITING

Norfolk, Virginia, 23502, United States
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im M Kopernika w Lodzi
RECRUITING

Lodz, 93 513, Poland

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA